Document is current
Any future updates will be listed below
-
Authors
Schäfer, Arne https://orcid.org/0000-0001-6600-3691
Kovacs, Magdolna Szilvia https://orcid.org/0000-0001-9215-6501
Eder, Anna https://orcid.org/0000-0002-6154-4322
Nigg, Axel https://orcid.org/0000-0001-5805-806X
Feuchtenberger, Martin https://orcid.org/0000-0001-8028-8099
- License Information
-
More Information
Article History
Received: 4 August 2023
Accepted: 30 October 2023
First Online: 16 January 2024
Declarations
:
: Dr. Schäfer reports personal fees from Amgen, AstraZeneca, Novo Nordisk Pharma GmbH, outside the submitted work. Dr. Kovacs has nothing to disclose. Dr. Eder has nothing to disclose. Dr. Nigg has nothing to disclose. Dr. Feuchtenberger reports personal fees from AbbVie, personal fees from Novartis, personal fees from Roche, and personal fees from UCB outside of the submitted work. All authors disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
: The study was approved by the Ethics Committee of the University of Würzburg, Würzburg, Germany, on 12 July 2018 (2/18-me).
: All patients provided written informed consent for blood analysis, study participation and publication of data.
